Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Alteogen reiterated that while a potential issuance of KRW 200.00B in Redeemable Convertible Preferred Shares (RCPS) is under consideration, nothing has been concretely finalized, and no lead manager agreement has been signed with Shinhan Securities.
📊 [Key Disclosure Details & Financial Highlights]
- Target News Report: “Alteogen, No. 1 KOSDAQ Cap, to Issue 200B RCPS… Shinhan Securities as Lead Manager” (Seoul Finance, 2024-11-21)
- Company’s Clarification Details:
- The reported KRW 200.00B RCPS issuance is currently being considered, but nothing has been finalized as of the disclosure date.
- Contrary to the media report, the company has not entered into a lead manager contract with Shinhan Securities.
- Scheduled Re-disclosure Date: 2025-02-20 (or when specific details are finalized)
- Prior Related Disclosures: Unconfirmed clarification disclosures submitted on 2024-11-21 and 2024-12-20
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Submission of Follow-up Re-disclosure on RCPS Issuance
This filing is an update stating that specific terms regarding the reported KRW 200.00B RCPS issuance and lead manager selection remain unconfirmed. Verifying whether a definitive corporate filing outlining the final decision is submitted on or before the re-disclosure target date of February 20, 2025, is important to track the final status of this capital raise. The finalized updates can be confirmed in subsequent filings such as the scheduled ‘Re-disclosure’ or ‘Decision on Paid-in Capital Increase’.
📢 Disclaimer & Source Information
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.
